AXSM

129.2404.75%
AM

Ari Maizel

Chief Commercial Officer

Mr. Ari Maizel, M.B.A., serves as Chief Commercial Officer of Axsome Therapeutics, Inc. from October 2024. Mr. Maizel was Executive VP & Head of Commercial of Axsome Therapeutics, Inc. from October 2023 until October 2024. Prior to joining Axsome, Mr. Maizel was the Vice President, U.S. Psychiatry at AbbVie where he oversaw sales and marketing for a multibillion-dollar franchise. Mr. Maizel held positions of increasing responsibility in sales and marketing throughout his career at AbbVie (formerly Allergan), Dendreon Corporation and Johnson & Johnson across a range of therapeutic areas, including CNS, immunology, oncology, gastroenterology and women’s health. Mr. Maizel began his career at ArrowPath Venture Partners, an early-stage technology investment fund and was a strategy consultant with Sg2, supporting hospitals and health systems around the world. Mr. Maizel serves as a Member of Advisory Board at Kaibo Engineering Group Corp. Mr. Maizel supports investments for ArrowPath Venture Capital. He concentrates on researching and analyzing potential investments, as well as assisting in portfolio company development. Prior to joining ArrowPath VC, Mr. Maizel served as an intern with Salomon Smith Barney. Mr. Maizel earned a Bachelor of Business Administration with a concentration in Finance from The George Washington University. He earned Master of Business Administration from Duke University.

Positions